1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

30 Jul 2022
Admin
News Article

Viiv Healthcare Mpp Sign New Voluntary Licensing Agreement To Expand Access To Innovative Long Acting Hiv Prevention Medicine

Viiv Healthcare, The Global Specialist Hiv Company Majority Owned By Gsk, With Pfizer And Shionogi As Shareholders, And The Medicines Patent Pool (Mpp), Announced The Signing Of A New Voluntary Licensing Agreement For Patents Relating To Cabotegravir Long-Acting (La) For Hiv Pre-Exposure Prophylaxis (Prep) To Help Enable Access In Least Developed, Low-Income, Lower Middle-Income And Sub-Saharan African Countries.Through This Agreement, Selected Generic Manufacturers Will Have The Opportunity To Develop, Manufacture And Supply Generic Versions Of Cabotegravir La For Prep, The First Long-Acting Hiv Prevention Medicine, In 90 Countries, Subject To Required Regulatory Approvals Being Obtained. It Is Expected That This Agreement Will Help To Enable At-Scale Access To Generic Cabotegravir La For Prep. This Announcement Comes Just Seven Months After The First Regulatory Approval Of Cabotegravir La For Prep In The World, By The Us Food And Drug Administration (Fda).Each Year, There Are Approximately 1.5 Million New Cases Of Hiv Worldwide, Most Of Which Occur In Resource-Limited Countries, With Women And Adolescent Girls Disproportionately Impacted. While Oral Prep Options Are Available In Many Countries, Challenges With Adherence And Stigma Have Limited Their Impact In Some Populations. Access To An Effective Long-Acting Hiv Prevention Option Could Significantly Contribute Towards The Goal Of Ending The Epidemic. The New Voluntary Licence Announced Today Builds On A Long-Standing Partnership Between Viiv Healthcare And Mpp, Which Has Been Highly Successful In Facilitating The Manufacture And Sale Of Generic Versions Of Oral Viiv Healthcare Medicines In Countries Most Affected By Hiv And Least Able To Pay For Treatment And Care. In Particular, Voluntary Licensing Has Enabled Access To Generic Products Containing Another Of Viiv Healthcare

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!